T1	Participants 78 132	Type 2 Diabetic Patients Poorly Controlled by Statins.
T2	Participants 728 791	DM subjects who had failed to achieve the optimal LDL-C targets
T3	Participants 901 974	patients who reached the LDL-C targets and changes in the levels of RLP-C
